Evidence map›Paper›PMID 33467609›Full record

ArticleMicroorganisms2021

Performance of a Four-Antigen

Ingrid L Scully, Yekaterina Timofeyeva, Arthur Illenberger, Peimin Lu, Paul A Liberator, Kathrin U Jansen, Annaliesa S Anderson

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Scaffold vaccination for prevention of orthopedic device infection.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Overcoming Immune Evasion inACS infectious diseases · 2025
    Review
  7. Article
  8. Article
  9. A promisingClinical and experimental vaccine research · 2025
    Review
  10. Review
  11. Conserved moonlighting protein pyruvate dehydrogenase induces robust protection againstProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Human MAIT Cells Respond toMicroorganisms · 2022
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ingrid L ScullyPfizer Vaccine Research & Development, Pearl River, NY 10965, USA.
Yekaterina TimofeyevaPfizer Vaccine Research & Development, Pearl River, NY 10965, USA.
Arthur IllenbergerPfizer Vaccine Research & Development, Pearl River, NY 10965, USA.
Peimin LuPfizer Vaccine Research & Development, Pearl River, NY 10965, USA.
Paul A LiberatorPfizer Vaccine Research & Development, Pearl River, NY 10965, USA.
Kathrin U JansenPfizer Vaccine Research & Development, Pearl River, NY 10965, USA.
Annaliesa S AndersonPfizer Vaccine Research & Development, Pearl River, NY 10965, USA.
Pfizer (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A

Indexed as

animal modelsClfAconjugated polysaccharideinvasive diseaseMntCprotectionSA4Ag vaccinesepsisStaphylococcus aureussurgery-associated infection

Identifiers

PMID33467609
PMCPMC7830931
OpenAlexW3120614934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.